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Hemodynamic improvement in patients suffering from both septic shock and renal failure who received 
hemofiltration suggested that an extrarenal epuration technique could be of interest in patients with septic shock 
alone. However, most of the studies using continuous veno-venous hemofiltration (CVVH) in this setting 
evidenced neither cytokine clearance nor significant reduction in their plasma level. Lack of significant clearance 
was explained in part by the small size of the membrane pores. Therefore, we investigated the effects of large-
pore membrane hemofiltration (LPHF) during endotoxic shock in pigs on interleukin 6 (IL-6) and interleukin 10 
(IL-10) clearances, and on right ventricular (RV)-vascular coupling. Thirteen anesthetized healthy pigs weighing 
20-30 kg were divided into two groups. In the Endo group (n = 6), the pigs received a 0.5-mg/kg endotoxin 
infusion over a period of 30 mins from TO to T30. In the EndoHF group (n = 7), LPHF (cutoff = 80 kDa) and an 
ultrafiltration rate of 45 mL/kg/h were started 30 mins after the end of the endotoxin infusion, from T60 to T240. 
In this model of porcine endotoxic shock, LPHF was responsible for a significant clearance of IL-6 (20 mL/min) 
and Il-10 (14 mL/min), and for an improvement in RV-vascular coupling.  
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Hemodynamic improvement in patients suffering from both septic shock and renal failure who received 
hemofiltration suggested that an extrarenal epuration technique could be of interest in patients with septic shock 
alone (1). The rationale for such interest derives from knowledge that part of the systemic effects of sepsis may 
be mediated by endogenous, water-soluble, small-(<0.5 kDa) and medium-sized (>0.5 kDa but <60 kDa) 
molecules and that their removal from the bloodstream may be of significant benefit. 
However, most of the studies using CVVH in this setting, even with a high ultrafiltration rate, evidenced neither 
cytokine clearance nor significant reduction in their plasmatic level. In best cases, clearance was limited and 
transient (2-4). Lack of significant clearance was explained in part by the small size of membrane pores. Indeed, 
the membrane cutoff in most of these studies was around 30 kDa, while molecular weight of the trimeric 
biologically active form of TNFα is more than 50 kDa, for example. 
Large-pore membrane hemofiltration (LPHF) leads (in ex vivo studies) to a cytokine clearance greater than in 
classic membranes. Membranes with a cutoff of 60 kDa, for example, resulted in a significant clearance of 
interleukin 6 (IL-6), interleukin 8, and interleukin 1 (5). 
According to this better cytokine clearance opportunity, we designed this study to investigate in vivo the effects 
of LPHF with an 80 kDa cutoff membrane on IL-6 and interleukin 10 (IL-10) clearances, and on right ventricular 
(RV)-vascular coupling. 
Materials and methods 
All experimental procedures and protocols used in this investigation were reviewed and approved by the Ethics 
Committee of the Medical Faculty of the University of Liège. The investigation conforms to the Guide for the 
Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH Publication no. 
85-23, revised 1996). 
The experiments were performed on 13 healthy pure pietran pigs of either sex weighing 20-30 kg. The animals 
were premedicated and anesthetized as described elsewhere (6). Systemic arterial pressure, pulmonary arterial 
pressure (PAP), and flow and (RV) pressure-volume loops were recorded and analyzed as described previously 
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(6). To assess RV-vascular coupling, we examined the Ees/Ea ratio. Ees represents the end-systolic RV elastance 
and Ea represents the pulmonary arterial elastance. 
In both groups, the animals received a 0.5-mg/kg endotoxin infusion (lipopolysaccharide from Escherichia coli 
serotype 0127:B8; Sigma Chemical, St. Louis, MO, U.S.A.) over 30 mins (from T0 to T30). They were then 
randomized into two groups. In the Endo group (n = 6), they received no further intervention while in the 
EndoHF group (n = 7), they underwent, from T60 onward, a zero-balance CWH at a rate of 45 mL/kg/h (7). A 
0.7-m2 large-pore (78 Å) membrane with a cutoff of 80 kDa (Sureflux FH 70, Nipro, Osaka, Japan) and a Baxter 
BM 25-BM 14 hemofiltration device (Baxter Health Care, Munich, Germany) were used. Ultrafiltrate was 
replaced in the postdilution mode by a bicarbonate-buffered hemofiltration fluid (Na+: 150 mM; K+: 3 mM; 
bicarbonate: 30 mM) at a temperature of 37°C. Anticoagulation of the extracorporeal circuit was achieved using 
a loading dose of 5000 IU of heparin followed by an anticoagulation regimen based on the activated clotting 
time (100-200 s). Rectal temperature was monitored every 30 min. 
Blood (before and after the membrane) and ultrafiltrate samples were taken at T0, T60, T120, and T240 to 
measure IL-6 (28 kDa) and IL-10 (19 kDa) concentrations using an ELISA test (Biosource, Paris, France). 
Clearance and sieving coefficients were calculated at T120 and T240 using the following formula: 
Sieving coefficient = 2. [UF]/([A] + [V]) 
Clearance (mL/min) = Sieving coefficient. 
Ultrafiltration rate (mL/min) 
where [UF] is the concentration in ultrafiltrate, [A] is the concentration in inlet supernatant, and [V] is the 
concentration in outlet supernatant. 
Plasma albumin concentration was measured at T60 and T240. 
Statistical analysis 
Data were presented as mean ± standard error of the mean. A two-way analysis of variance for repeated 
measurements before (from T0 to T60) and after (from T90 to T240) the start of LPHF gave P values for time 
and group effects (Statistica, Statsoft, Inc., Tulsa, OK, U.S.A.). P < 0.05 was considered statistically significant. 
Results 
The mean systemic arterial pressure, heart rate, and cardiac output did not differ between Endo and EndoHF 
groups from T0 to T240. The mean PAP reached its first maximum at T30 in the Endo and EndoHF groups. 
After the start of LPHF (from T90 to T240), the mean PAP in the EndoHF group remained lower than the mean 
PAP in the Endo group (P < 0.05) (Fig. 1). 
After the start of LPHF (from T90 to T240) pulmonary Ea values in the EndoHF group remained lower than 
Endo group values (P < 0.05), while the time evolution of Ees remained similar in the two groups (Fig. 2). 
Consequently, the Ees/Ea ratio decreased slightly from TO to T30 in both groups. From T90 to T240, the Ees/Ea 
ratio in the EndoHF group remained greater than 2, while in the Endo group, the Ees/Ea ratio decreased 
progressively (Fig. 2). This difference between the two groups was significant (P < 0.05). 
No significant differences in rectal temperature occurred between groups from T0 to T240. 
At T120 and T240, the IL-6 clearance was 22 ± 7 and 15 ± 3 mL/min, respectively. The IL-6 sieving coefficient 
was 0.84. At T120 and T240, the IL-10 clearance was 14 ± 4 and 10 ± 7 mL/min, respectively. The sieving 
coefficient was 0.55. At T60 and T240, the plasmatic albumin concentration was 24 ± 4 and 23 ± 4 g/L, 
respectively (P = 0.13). 
Discussion 
The major findings of our study are that LPHF is responsible for a significant clearance of IL-6 and IL-10, and 
prevents the RV-vascular uncoupling that habitually occurs during the late phase of endotoxic shock. The 
difference between the two groups during the second phase of endotoxic shock resulted from a difference in 
pulmonary vascular resistance as all the other factors contributing to the Ea value remained similar. 
The effects of LPHF on RV-vascular coupling were never tested previously. At the best, Grooten-dorst et al. 
tested the effects of CWH with an ultra-filtration rate of 6 L/h on RV ejection fraction in pigs with endotoxin-
induced shock. In their model, the authors concluded that high-volume hemofiltration improved RV ejection 
fraction and cardiac performance by the removal of vasoactive mediators responsible for myocardial depression 
(8). LPHF did not improve the mean systemic arterial pressure and cardiac output, which remained similar in 
both groups. These results are in accordance with those of Stein et al. (9), but they are in opposition with those of 
Grootendorst, who showed an increase in the mean arterial pressure and cardiac output in endotoxic pigs 
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receiving continuous high-volume hemofiltration (8,10). Lee et al. found no significant increase in the mean 
arterial pressure in endotoxic pigs receiving LPHF (100 kDa pore size membrane), although it increased survival 
rate (11). 
Clearance values and sieving coefficients obtained in the present study are largely superior to those obtained 
with standard hemofiltration membranes. Heering et al. measured an IL-6 sieving coefficient of 0.04, and IL-10 
was undetectable in the ultrafiltrate (4). In the study of Kellum et al., the IL-10 concentration in ultrafiltrate was 
very low and the IL-6 clearance was 3.3 mL/min (3). 
 
FIG. 1. Evolution of (a) mean systemic arterial pressure, (b) mean PAP, (c) heart rate, and (d) mean cardiac 
output during endotoxic shock in Endo and EndoHF groups. The Endo group received an endotoxin infusion 
(LPS) over 30 min from T0 to T30. The EndoHF group received an endotoxin infusion over 30 min from T0 to 
T30 and an LPHF from T60 to T240. *P < 0.05 for time effect; †P < 0.05 for group effect. Data are presented as 
mean ± SEM. 
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Cytokines are considered to be important mediators in the pathophysiology of septic shock, and it was suggested 
that the nonspecific and continuous removal of pro- and anti-inflammatory soluble mediators may be the most 
logical and adequate approach to a complex and long-running process such as sepsis (12). Several studies 
demonstrated significant removal rates of inflammatory cytokines from the circulation of septic patients by 
CWH (4,13,14). As one of the mechanisms of cytokine removal is convective clearance (3), increasing 
convective clearance should increase blood purification effectiveness. One way to achieve this goal is the use of 
larger-pore membranes (15). In vitro, large-pore membranes can lead to cytokine clearance comparable to that 
currently achieved for urea during standard continuous renal replacement therapy (5). In vivo, Morgera et al. 
found that a 60-kDa cutoff membrane can lead to IL-6 clearance similar to that of our study (16). In the present 
work, an 80-kDa cutoff membrane leads to significant cytokine clearances for IL6 and IL-10, without significant 
protein loss as demonstrated by albumin concentration values at T60 and T240. 
 
FIG. 2. Evolution of (a) Ea, (b) Ees, and (c) Ees/Ea during endotoxic shock in Endo and EndoHF groups. The 
Endo group received an endotoxin infusion (LPS) over 30 min from T0 to T30. The EndoHF group received an 
endotoxin infusion over 30 min from T0 to T30 and an LPHF from T60 to T240. *P < 0.05 for time effect, †P < 




The use of LPHF in this model of porcine endotoxic shock was responsible for a significant clearance of IL-6 
and IL-10, and an improvement in RV-vascular coupling by preventing increase in pulmonary Ea. 
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